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Objectives: To compare the long-term outcome for pregnant~puerperal women with iliofemoral venous thrombosis treated 
either with thrombectomy and additional anticoagulants orwith anticoagulants alone. 
Design" Retrospective study of two treatment methods. 
Materials" Thirty women with iliofemoraI venous thrombosis during pregnancy or puerperium were treated with 
thrombectomy and additional anticoagulants. Twenty-five women, with the same condition, treated with anticoagulants 
only were obtained from a registry. The mean follow-up time for both groups was 9 years. The patients of the two groups 
were well matched, had the same risk factor score and were comparable except for duration of symptoms before 
treatment. 
Methods: The follow-up comprised history and clinical examination, colour Duplex ultrasound and venous train-gauge 
plethysmography. 
Results" Patency of iliac veins, symptoms of chronic venous disease, venous emptying and venous reflux did not differ 
between the groups. A significant reduction of outflow was found in 20% of the surgically treated patients and 16% of the 
controls, Impaired muscle pump function was seen in less than half of the patients in both groups. 
Conclusions" Surgical thrombectomy does not offer any advantage over anticoagulation treatment alone in the long-term 
outcome for patients with iliofemoral venous thrombosis during pregnancy or puerperium. 
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Introduction 
The incidence of venous thromboembolism during 
pregnancy is 0.1-1 per 1000 live births. After delivery 
the figure is two to three times higher. There is an even 
risk during the whole pregnancy but iliofemoral 
venous thromboses are more common during the last 
trimester and shortly after pregnancy. 1 The reasons for 
this may be increased pressure on the iliac veins by the 
enlarged uterus, pre-eclampsia and hypercoagulabil- 
ity induced by the pregnant state. The fibrinolytic 
capacity is reduced during the pregnancy. After 
delivery these risk factors will normalise but the 
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hypercoagulability will remain for 3-6 weeks after 
delivery. Other risk factors for venous thrombosis are, 
however, also important for the development of 
iliofemoral venous thrombosis. 2 
The treatment of venous thrombosis in pregnant 
women is mainly anticoagulation with heparin with 
the aim to stop propagation of the thrombus and 
decrease the risk of embolism. Fibrinolytic treatment is 
contraindicated due to the risk of major haemorrhage 
and ablatio placentae but may be indicated as a life- 
saving measure for massive pulmonary embolism if 
surgical intervention is not possible. Catheter-directed 
thrombolysis may prove to be an adjunctive measure 
in selected cases but has not yet been reported as a 
treatment of venous thrombosis during pregnancy 3'4 
due to the expected risk to the foetus. Surgical 
thrombectomy with a temporary arteriovenous fistula 
has been advocated in addition to anticoagulant 
treatment for iliofemoral venous thrombosis, l's-~° Any 
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method that reduces the risk of future venous insuffi- 
ciency would be particularly important in young 
patients with a long life expectancy during which 
post-thrombotic syndrome may develop. However, 
surgical thrombectomy for acute iliofemoral venous 
thrombosis is still controversial and has not been 
widely accepted. 7'11 
The purpose of the present s udy was to compare 
the long-term outcome for pregnant/puerperal 
women with iliofemoral venous thrombosis, who had 
been treated with surgery and anticoagulants, with 
those who had received only anticoagulant 
treatment. 
Patients and Methods 
Patients 
During 1978-1989, 39 women with iliofemoral venous 
thrombosis during pregnancy or puerperium under- 
went thrombectomy with a temporary arteriovenous 
fistula. Thrombectomy in the Stockholm area was 
exclusively performed at Karolinska Hospital during 
that period. However, not all hospitals in the Stock- 
holm county referred pregnant or puerperal women 
with iliofemoral venous thrombosis to the Karolinska 
Hospital. The main criterion for selection for operation 
was a short duration of symptoms. 5'6 The results from 
the Karolinska Hospital have been published pre- 
viously but no control group was involved in the 
treatment of iliofemoral venous thrombosis at this 
hospital. 2"6"12n3 Thirty of the surgically treated women 
were able to take part in a follow-up examination, 
which was done between the end of 1992 and January 
1994. 
The control group was obtained from a registry of 
patients with venous thrombosis during or after 
pregnancy treated at other hospitals in the region 
during the same period. Thirty-seven pregnant or 
puerperal women according to hospital and X-ray 
records with iliofemoral venous thrombosis received 
anticoagulant treatment only. Twenty-five of these 
women could be traced and agreed to take part in a 
follow-up examination which was performed uring 
the same period as the surgical group. 
During pregnancy or puerperium the women had 
been treated as follows: Heparin treatment was started 
at the time of diagnosis and initially given as an i.v. 
continuous infusion and continued after 5-10 days 
with s.c. injections. The heparin-dose was generally 
adjusted to an APT time of 1.5-2 times prolongation of
the normal time. Elastic stockings and early mobilisa- 
tion were used for general treatment. During treat- 
ment with subcutaneous heparin, the anticoagulation 
effect in the surgically treated women was mostly 
controlled with the level of plasma heparin concentra- 
tion (anti-Xa activity). A dose reduction comparable to
prophylaxis was initiated after 4 weeks, a total length 
of therapy was planned for about 6 months and at 
least 6 weeks postpartum. After delivery most of the 
women were put on oral anticoagulants. In the 
nonsurgically treated group two women with post- 
partum thrombosis received streptokinase. In the 
surgically treated group 21 women received oral 
anticoagulant therapy after delivery and 19 in the 
other group. The duration of therapy was 3.5-9 
months and 3-12 months respectively. The mean age 
at onset of symptoms and follow-up, mean follow-up 
time, duration of symptoms before treatment and 
gestational ge are presented in Table 1. The patients 
in the two treatment groups were comparable except 
for the duration of symptoms before treatment/ 
operation. 
The extent of venous thrombosis as judged from the 
phlebography report, and for most operated patients, 
computerised tomography is shown in Table 2. The 
numbers with extension from iliac vein to groin, thigh 
and popliteal vein were comparable in both treatment 
Table 1. Basic data of patients with iliofemoral venous thrombosis during pregnancy or puerperium. The two treatment options, 
thrombectomy and anticoagulants or anticoagulants only are comparable xcept for the duration of symptoms before treatment/operation 
Thrombectomy and Anticoagulation 
anticoagulation (n=30) (n=25) 
(Range) (Range) 
Number of patients with venous thrombosis. Pregnancy/puerperium 
Family history of venous thrombosis 
Mean age at onset ofsymptoms (years) 
Mean age at follow-up (years) 
Mean follow-up time (years) 
Duration of symptoms before treatment/operation (days) 
Duration of pregnancy at diagnosis (weeks) 
Diagnosis during puerperium, days after delivery 
21/9 18/7 
15 12 
29 (1541) 28 (21-36) 
37 (25-49) 37 (25-47) 
9 (3-14) 9 (4-16) 
4 (1-14) 8 (1-28)* 
31 (11-40) 26 (11-38) 
9 (1-16) 14 (2-30) 
*p<0.05. 
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Table 2. Extension of thrombosis before treatment 
Thrombectomy and Anticoagulation 
anticoagulation (n=30) (n=25) 
From iliac vein to: 
Groin 9 11 
Thigh 12 7 
Popliteal vein 9 7 
groups. Five patients in the thrombectomy group and 
six in the nonoperative group had rethrombosis 
between the initial event and the follow-up investiga- 
tion. Sixteen women in the operated group had 23 new 
pregnancies and 18 nonoperated women had 37 new 
pregnancies. 
In the surgically treated group 6/30 had post- 
operative complications. Two had local infections, one 
had seroma. One woman had several episodes of 
severe bleeding and was reoperated. Her pregnancy 
was terminated prematurely due to bleeding compli- 
cations. Two had recurrent hrombosis one of which 
was found to have protein C deficiency. In the 
conservatively treated group 4/25 had complications, 
one had probable pulmonary embolism and one had 
osteoporosis and vertebral fractures. One woman had 
haematuria leading to termination of pregnancy 
before term, and one had extensive swelling of the 
affected leg. No clinical signs of pulmonary embolism 
were observed in the surgically treated group. After 
the initial episode most patients were investigated for 
defects of blood coagulation or fibrinolysis defects. In 
the operated group there were two patients with anti- 
cardiolipin antibodies, one had increased lupus anti- 
coagulant, one had subnormal levels of free protein S 
and one protein C deficiency. In the nonoperated 
group one had subnormal levels of free protein S and 
one lupus anticoagulant. The mean risk factor score 14 
was 1.5 in the surgically treated and 1.2 in the control 
group. 
At follow-up 
Clinical examination and history included family 
history of thromboembolism, history of thromboem- 
bolism and recurrencies, pregnancies and relevant 
diseases, present and past postthrombotic symptoms 
like bursting pain on walking or during exercise, leg 
ulcer or leg swelling. The clinical examination 
recorded signs of leg swelling, pigmentation, ulcer 
and varicose veins. The examination was performed 
by one surgeon and one obstetrician. 
Colour Duplex ultrasound. Duplex scanning was per- 
formed with a colour flow Duplex imager (Acuson 
128, Mountain View, Ca, U.S.A.). Depending on the 
depth of the vessel to be examined an imaging 
transducer of 3 or 5 MHz was selected in conjunction 
with a 2.5 or 3.5 MHz pulsed Doppler. With the patient 
supine, venous flow was evaluated in the inferior 
vena cava, common and external iliac veins, femoral 
and popliteal veins. The presence of spontaneous flow 
was evaluated as well as respiratory variation. The 
occurrence of post-thrombotic wall changes (irregu- 
larities, wall thickening, decreased lumen) was 
denoted. With the patient in standing or sitting 
position with dependent leg, valvular function was 
evaluated in the femoral, popliteal and posterior tibial 
veins following distal manual compression. 15 Only 
reflux with a duration more than 0.5 s was considered 
significant. 16 
Venous train-gauge plethysmography. Venous outflow 
capacity was measured with a computerized strain- 
gauge plethysmograph (Phlebotest, Eureka AB, Swe- 
den). Venous emptying (VE) during the first second 
following release of venous occlusion was measured 
with strain-gauge wires around the thickest part of the 
calf as earlier described.17 AVE less than 50ml/100ml 
per min was used to indicate deep venous obstruction. 
Using the same equipment (see above) volume 
changes were measured uring and after a standar- 
dised muscular exercise of 15 knee-bends, but now 
with the wires applied just proximal to the malleolus. 
The test was in all cases repeated after occlusion of the 
superficial veins below the knee. Half-refilling time 
(T1/2) and refilling volume (RV) were calculated, is T 
1/2 less than 7 s and RV less than 1.0 ml/100 ml were 
considered abnormal indicating dysfunction of 
venous valves below the knee and/or significantly 
decreased muscle pump function. Volume increase at 
tilting from supine to nearly standing position was 
measured with and without occlusion of superficial 
veins below the knee by the use of strain-gauge wires 
around the thickest part of the calf (EC 4 Plethysmo- 
graph, DE Hokanson Inc., U.S.A.). This permitted 
quantification ofvenous reflux from the thigh down to 
the lower leg in deep and superficial veins, a9"2° A 
volume increase xceeding 1.3 ml/100 ml per 10 s was 
considered abnormal. 
Ethics and statistics 
All patients gave their consent o participate in the 
investigation and the follow-up was approved by the 
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Medical Ethics Committ6e of Karolinska Hospital. 
Differences of means were tested for statistical sig- 
nificance by the use of two-sided t-tests and propor- 
tions by Chi-square test with Yate's correction. Statis- 
tical significance was assumed if p < 0.05. 
Results 
Colour Duplex ultrasound emonstrated post-throm- 
botic changes in 53% of the surgically treated and in 
52% of the nonsurgically treated patients. This 
included eight iliac vein occlusions and one short 
femoral mid-thigh occlusion in the former group and 
three iliac vein occlusions in the latter. There was no 
difference in VE between the two groups. A sig- 
nificantly reduced outflow capacity (VE < 50 ml/100 
ml per ain) was found in 20% of the surgically treated 
and 16% of the nonsurgically treated patients. There 
were no differences in deep venous reflux between the 
two groups. Reflux in femoral or popliteal veins was 
found in 10 (33%) of the thrombectomised patients 
and in nine (36%) of the patients treated with only 
anticoagulation. Venous reflux at thigh and popliteal 
level was further demonstrated by an abnormal 
volume increase at tilting ( > 1.3 ml/100 ml per 10 s) in 
33% of surgically treated and 36% of nonsurgically 
treated patients. In both groups volume increase was 
significantly reduced following occlusion of super- 
ficial veins suggesting that venous reflux to some 
extent occurred also in the superficial venous 
system. 
Plethysmographic measurements of volume 
changes at ankle level during exercise was abnormal 
in 47% of the thrombectomised patients and in 48% of 
the patients treated with only anticoagulation. Here, 
no effect could be noted by occlusion of superficial 
veins below the knee. Thus, abnormalities in the 
superficial venous system could be neglected as a 
contributor to the impaired muscle pump function 
seen in approximately half of these patients. When the 
results from the three different ypes of plethysmo- 
graphic measurements were combined (venous out- 
flow capacitN calf volume increase at tilting and 
measurements at ankle level during exercise), 33% of 
the patients in the operated group and 28% of the 
nonoperated patients had all values within the normal 
range. The results from noninvasive laboratory inves- 
tigations are summarised in Table 3. 
About half of the patients in both groups had no 
subjective symptoms ome 30% of surgically treated 
and 24% of the nonsurgicaUy treated patients experi- 
enced leg swelling. Significant pain on fast walking or 
Table 3. Results of colour Duplex ultrasound and venous strain- 
gauge plethysmography (mean + S.D.) at follow-up of patients with 
iliofemoral venous thrombosis during pregnancy/puerperium 
Thrombectomy and Anticoagulation 
anticoagulation (n=30) (n=25) 
Number of patients 22 (73%) 22 (88%) 
with patent iliac vein 
Number of patients with 11 (37%) 9 (36%) 
reflux in any deep vein* 
Venous emptying 74_+25 74_+21 
(ml/100 ml per rain) 
Half-refilling time, 10.1_+6.0 8.1_+3.9 
T1/2 (seconds) 
Refilling volume, 1.03_+0.49 1.02+0.48 
RV (ml/100 ml) 
Volume increase at 1.25_+0.85 1.42_+0.96 
tilting (ml/100 ml per 10 s) 
No significant difference between the two groups. 
*=femoral, popliteal or posterior tibial veins. 
during exercise was present in 17% of surgically 
treated and 28% of the nonsurgically treated patients. 
Varicose veins at examination or operated during 
follow-up period was a minor problem and equally 
distributed in both groups. Only one patient, treated 
with anticoagulation alone had hyperpigmentation at 
the ankle and had had a venous ulcer (Table 4). 
Discussion 
In iliofemoral venous thrombosis it has been an open 
question as to whether the long-term results are 
improved by thrombectomy compared to standard 
treatment with anticoagulation. There is only one 
prospective randomised study that could elucidate 
this question. 1° However, women during pregnancy 
were not randomised in that study but obviously, in 
most cases, underwent surgical thrombectomy. The 
follow-up period was 5 years and the clinical and 
physiological results were slightly better following 
venous thrombectomy and anticoagulation than after 
Table 4. Results of clinical examination atfollow-up 9 years after 
iliofemoral venous thrombosis 
Thrombectomy and Antieoagulation 
anticoagulation (n=30) (n=25) 
No symptoms 16 (53%) 
Leg swelling 9 (30%) 
Venous claudication 5 (17%) 
Previous leg ulcer 0 
Varicose veins, present at 7 (23%) 
examination roperated 
during follow-up eriod 
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anticoagulation alone. Iliofemoral venous patency and 
venous outflow were clearly better following surgical 
than medical treatment, but valvular competence was 
not clearly preserved by the surgical procedure in that 
study. The results of the present comparative study of 
iliofemoral venous thrombosis during pregnancy and 
puerperium with a mean follow-up time of 9 years do 
not support surgery. The present results may indicate 
that there is a difference in treatment results between 
mixed patients groups and young women during 
pregnancy or puerperium. Since the difference in 
outcome is not obvious, anticoagulation treatment is 
still an acceptable alternative. 
The main criteria for acceptance for thrombectomy 
in our patients were a short duration of symptoms and 
a young patient. The mean duration of symptoms in 
the two groups of the present study was shorter in the 
surgical group. The number of rethromboses between 
the first event and follow-up were comparable 
between the two groups, but the number of consec- 
utive pregnancies eemed to be higher in the non- 
operative treatment group. In all other respects the 
patients of the two treatment groups were well 
matched. Thus, as randomised studies are lacking for 
pregnant women, our case control analysis seems 
justified. 
A critical analysis of any treatment method on 
thrombotic disease should include the following vari- 
ables: risk factors and predisposing conditions, extent 
of thrombus and site involvement, pulmonary emboli- 
zation, mortalit)~ bleeding and septic complications 
and injury to valves. 14 Data on side effects and 
postoperative complications are seldomly included. 
To establish the efficacy of thrombectomy and anti- 
coagulation during pregnancy or puerperium as com- 
pared with anticoagulation onl~ trials are needed in 
patients with comparable coagulation and fibrinolytic 
dysfunctions as well as the extension and age of the 
thrombus. It may be too difficult to obtain sufficiently 
large number of pregnant women with iliofemoral 
vein thrombosis to answer which treatment method 
most effective, safe and cost effective. On the other 
hand there are several reports based on personal 
experience of the surgeons. 1'7-9'11 The experience of 
thrombectomy during pregnancy or puerperium has 
increased, but still recent reports with follow-ups 
include less than 150 patients. 
Duplex ultrasound scanning has rapidly become the 
method of choice for evaluating venous valvular 
function and obstructive venous disease. 21'z2 The 
noninvasive nature makes this method especially 
useful in follow-up studies and when there is a need 
of repetitive evaluations. 23'24 The introduction of 
colour flow imaging facilitates identification of pelvic 
veins, indeed in the present study with the use of 
overnight fasting the major deep venous segments 
from the inferior vena cava to the posterior tibial veins 
could be visualised in all patients. The results from 
ultrasonographic evaluation showed no difference 
between the two patient groups regarding occurrence 
of residual venous occlusion, sites and occurrence of 
deep venous reflux or morphologic/post-thrombotic 
venous wall irregularities. To further evaluate func- 
tional changes following iliofemoral thromboses all 
patients were subjected to quantitative plethysmo- 
graphic measurements of venous outflow capacity, 
venous reflux and muscle pump function, all pointing 
to a negligible long-term effect of thrombectomy 
compared to only anticoagulation in this patient 
group. It is worth noting that with the combination of 
three different plethysmographic methods measuring 
different types of venous dysfunction, 25 no abnor- 
malities were seen in 31% of the patients 9 years after 
an iliofemoral venous thrombosis. 
The relatively mild functional abnormalities dem- 
onstrated by noninvasive physiological evaluation fits 
well with the results from clinical examination with 
surprisingly mild signs and symptoms at follow-up in 
both treatment groups. Almost 50% of the patients 
were found to be completely asymptomatic. The 
literature presents conflicting results regarding out- 
come of conservative treatment in patients with 
different ypes of deep venous thrombosis and mixed 
populations. 26-28 One explanation might be that the 
introduction of graduated compression stockings and 
regular supervision used in more recently presented 
follow-up studies 26 provide a beneficial outcome 
compared to the poor prognosis reported earlier. The 
results from the present study clearly indicate that 
conservatively treated iliofemoral venous thrombosis 
during pregnancy do not carry a high risk of later 
post-thrombotic complaints as reported in some other 
studies. 1°,29,3° 
It is concluded that surgical thrombectomy offers no 
advantage over anticoagulant treatment alone for the 
long-term outcome in cases of iliofemoral venous 
thrombosis. In all cases there is a high degree of 
recanalisation of the thrombosed iliac veins and 
contrary to previous reports, long-term symptoms 
after proximal vein thrombosis eem to be relatively 
mild in both groups. The early advantage of throm- 
bectomy shown in other studies may have little 
subsequent clinical relevance to justify surgery. 
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